Patents Assigned to HELION BIOTECH APS
-
Patent number: 11225526Abstract: The invention relates to antibodies to MASP-2 and functional equivalents thereof. In particular, the invention relates to MASP-2 antibodies capable of inhibiting the function of MASP-2. The invention furthermore discloses MASP-2 epitopes, wherein antibodies recognising said epitopes are in particularly useful for inhibiting MASP-2 activity. The invention also relates to methods of producing said antibodies, methods of inhibiting MASP-2 activity as well as to pharmaceutical compositions comprising the MASP-2 antibodies.Type: GrantFiled: February 22, 2021Date of Patent: January 18, 2022Assignee: Helion Biotech ApSInventors: Flemming Larsen, Ulla Wahlers
-
Patent number: 11008405Abstract: The invention relates to antibodies to MASP-2 and functional equivalents thereof. In particular, the invention relates to MASP-2 antibodies capable of inhibiting the function of MASP-2. The invention furthermore discloses MASP-2 epitopes, wherein antibodies recognising said epitopes are in particularly useful for inhibiting MASP-2 activity. The invention also relates to methods of producing said antibodies, methods of inhibiting MASP-2 activity as well as to pharmaceutical compositions comprising the MASP-2 antibodies.Type: GrantFiled: January 7, 2020Date of Patent: May 18, 2021Assignee: Helion Biotech ApSInventors: Flemming Larsen, Ulla Wahlers
-
Patent number: 11008404Abstract: The invention relates to antibodies to MASP-2 and functional equivalents thereof. In particular, the invention relates to MASP-2 antibodies capable of inhibiting the function of MASP-2. The invention furthermore discloses MASP-2 epitopes, wherein antibodies recognising said epitopes are in particularly useful for inhibiting MASP-2 activity. The invention also relates to methods of producing said antibodies, methods of inhibiting MASP-2 activity as well as to pharmaceutical compositions comprising the MASP-2 antibodies.Type: GrantFiled: December 4, 2018Date of Patent: May 18, 2021Assignee: Helion Biotech ApSInventors: Flemming Larsen, Ulla Wahlers
-
Patent number: 10189909Abstract: The invention relates to antibodies to MASP-2 and functional equivalents thereof. In particular, the invention relates to MASP-2 antibodies capable of inhibiting the function of MASP-2. The invention furthermore discloses MASP-2 epitopes, wherein antibodies recognizing said epitopes are in particularly useful for inhibiting MASP-2 activity. The invention also relates to methods of producing said antibodies, methods of inhibiting MASP-2 activity as well as to pharmaceutical compositions comprising the MASP-2 antibodies.Type: GrantFiled: June 19, 2015Date of Patent: January 29, 2019Assignee: Helion Biotech ApSInventors: Flemming Larsen, Ulla Wahlers
-
Patent number: 9441262Abstract: The invention relates to the discovery and characterization of mannan binding lectin-associated serine protease-2 (MASP-2), a new serine protease that acts in the MBLectin complement fixation pathway.Type: GrantFiled: September 19, 2013Date of Patent: September 13, 2016Assignee: Helion Biotech ApSInventors: Jens Chr. Jensenius, Steffen Thiel
-
Patent number: 9096676Abstract: The invention relates to antibodies to MASP-2 and functional equivalents thereof. In particular, the invention relates to MASP-2 antibodies capable of inhibiting the function of MASP-2. The invention furthermore discloses MASP-2 epitopes, wherein antibodies recognizing said epitopes are in particularly useful for inhibiting MASP-2 activity. The invention also relates to methods of producing said antibodies, methods of inhibiting MASP-2 activity as well as to pharmaceutical compositions comprising the MASP-2 antibodies.Type: GrantFiled: May 12, 2004Date of Patent: August 4, 2015Assignee: Helion Biotech APSInventors: Flemming Larsen, Ulla Wahlers
-
Publication number: 20140134641Abstract: The invention relates to the discovery and characterization of mannan binding lectin-associated serine protease-2 (MASP-2), a new serine protease that acts in the MBLectin complement fixation pathway.Type: ApplicationFiled: September 19, 2013Publication date: May 15, 2014Applicant: Helion Biotech ApSInventors: Jens Chr. Jensenius, Steffen Thiel
-
Patent number: 8551790Abstract: The invention relates to the discovery and characterization of mannan binding lectin-associated serine protease-2 (MASP-2), a new serine protease that acts in the MBLectin complement fixation pathway.Type: GrantFiled: January 26, 2012Date of Patent: October 8, 2013Assignee: Helion Biotech ApSInventors: Jens Chr. Jensenius, Steffen Thiel
-
Publication number: 20120219965Abstract: The invention relates to the discovery and characterization of mannan binding lectin-associated serine protease-2 (MASP-2), a new serine protease that acts in the MBLectin complement fixation pathway.Type: ApplicationFiled: January 26, 2012Publication date: August 30, 2012Applicant: HELION BIOTECH APSInventors: Jens Chr. Jensenius, Steffen Thiel